Analyst resumed coverage on Ardent Health Partners with a new price target
$ARDT
Hospital/Nursing Management
Health Care
Analyst resumed coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $20.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/17/2025 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 11/14/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 10/14/2025 | $19.00 | Neutral | Goldman |
| 9/10/2025 | $17.00 | Buy | UBS |
| 7/16/2025 | $14.60 | Neutral → Underperform | BofA Securities |
| 12/17/2024 | $20.00 | Neutral | Analyst |
| 11/6/2024 | $22.00 → $19.00 | Buy → Neutral | BofA Securities |
| 10/11/2024 | $24.00 | Overweight | KeyBanc Capital Markets |
KeyBanc Capital Markets downgraded Ardent Health from Overweight to Sector Weight
Morgan Stanley downgraded Ardent Health from Overweight to Equal-Weight
Goldman initiated coverage of Ardent Health with a rating of Neutral and set a new price target of $19.00
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Wednesday, June 10, 2026, in Miami, Florida. Members of the management team will participate in a fireside chat on June 10, 2026, at 11:20 a.m. ET. A live audio webcast of the event will be available in the Investor Relations section of the Company's website, at ir.ardenthealth.com. A replay will be accessible on the same page following the session. In conjunction with the conference, the Ardent Health management team will be available to participate in one-on
Mr. Caspers brings decades of operational expertise and a deep understanding of Ardent Health's mission to enhance healthcare access and service Transition positions Ardent Health for its next phase of growth centered on operational efficiency and sharpening execution, building on the strong foundation established under Marty Bonick's leadership Reaffirms full-year 2026 Adjusted EBITDA guidance Ardent Health (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that Dave Caspers has been appointed President and Chief Executive Officer, effective immediately. Mr. Caspers, who previously s
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., has partnered with FUJIFILM Healthcare Americas Corporation to implement its Synapse® enterprise imaging solutions across Ardent's acute care hospital footprint across six states. Fujifilm's Synapse Enterprise Imaging solutions will provide Ardent clinicians with a single, holistic view of patient imaging data across various departments, including radiology and cardiology, through a unified Fujifilm Synapse Diagnostic PACS viewer. Having centralized access to all patient imaging in Synapse VNA improves workflow efficiency by streamlining operations across different departmen
8-K - Ardent Health, Inc. (0001756655) (Filer)
8-K - Ardent Health, Inc. (0001756655) (Filer)
10-Q - Ardent Health, Inc. (0001756655) (Filer)
Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2026. First Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA(1) $124 million 26.3% growth Y/Y Adjusted EBITDAR(1) $16
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2026 results after the market closes on Tuesday, May 5, 2026. A conference call will be held the following day, Wednesday, May 6, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, do
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in o
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)